We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$9.03B
AUM Growth
-$1.37B
Cap. Flow
-$1.22B
Cap. Flow %
-13.56%
Top 10 Hldgs %
18.31%
Holding
2,015
New
576
Increased
314
Reduced
307
Closed
636

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$18.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$17.4M
3
INSM icon
Insmed
INSM
+$16.1M
4
GILD icon
Gilead Sciences
GILD
+$15.8M
5
K
Kellanova
K
+$15.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.58%
2 Healthcare 3.09%
3 Consumer Discretionary 2.5%
4 Technology 1.62%
5 Financials 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LENZ
401
CALL
LENZ Therapeutics
LENZ
$133M
$5.13M 0.06%
+175,000
New +$4.76M
W icon
402
PUT
Wayfair
W
$14.2B
$5.11M 0.06%
100,000
PPLI
403
CALL
People Inc
PPLI
$2.85B
$5.11M 0.06%
+136,800
New +$4.94M
CNK icon
404
Cinemark Holdings
CNK
$3.93B
$5.1M 0.06%
169,000
+81,611
+93% +$2.47M
PENN icon
405
PUT
PENN Entertainment
PENN
$2.38B
$5.09M 0.06%
285,000
-240,000
-46% -$3.77M
CG icon
406
CALL
Carlyle Group
CG
$14.8B
$5.09M 0.06%
+99,000
New +$4.26M
VKTX icon
407
CALL
Viking Therapeutics
VKTX
$3.49B
$5.04M 0.06%
190,100
-102,100
-35% -$2.69M
NBIX icon
408
PUT
Neurocrine Biosciences
NBIX
$15.2B
$5.03M 0.06%
40,000
-110,300
-73% -$12.6M
LITE icon
409
CALL
Lumentum
LITE
$75.3B
$4.99M 0.06%
52,500
BSX icon
410
CALL
Boston Scientific
BSX
$63.6B
$4.94M 0.05%
46,000
+500
+1% +$50.6K
BRBR icon
411
BellRing Brands
BRBR
$1.06B
$4.92M 0.05%
+85,000
New +$5.67M
XLY icon
412
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.1B
$4.89M 0.05%
+45,032
New +$4.6M
AZN icon
413
CALL
AstraZeneca
AZN
$251B
$4.89M 0.05%
35,000
-115,000
-77% -$16.1M
GLW icon
414
Corning
GLW
$124B
$4.89M 0.05%
93,000
-4,545
-5% -$213K
HUM icon
415
Humana
HUM
$47.6B
$4.89M 0.05%
+20,000
New +$4.99M
SG icon
416
PUT
Sweetgreen
SG
$813M
$4.86M 0.05%
+326,800
New +$5.39M
QURE icon
417
PUT
uniQure
QURE
$2.99B
$4.83M 0.05%
+346,500
New +$4.66M
SNOW icon
418
Snowflake
SNOW
$114B
$4.77M 0.05%
21,300
+19,600
+1,153% +$3.54M
GE icon
419
GE Aerospace
GE
$319B
$4.76M 0.05%
+18,500
New +$4.06M
APH icon
420
CALL
Amphenol
APH
$191B
$4.76M 0.05%
+96,400
New +$3.94M
CAPR icon
421
PUT
Capricor Therapeutics
CAPR
$498M
$4.74M 0.05%
477,400
+327,400
+218% +$3.46M
SNDX icon
422
Syndax Pharmaceuticals
SNDX
$1.62B
$4.72M 0.05%
504,471
+322,571
+177% +$3.55M
GEHC icon
423
GE HealthCare
GEHC
$28.9B
$4.7M 0.05%
63,500
+45,250
+248% +$3.15M
C icon
424
Citigroup
C
$228B
$4.68M 0.05%
+55,000
New +$3.98M
ETN icon
425
CALL
Eaton
ETN
$152B
$4.64M 0.05%
+13,000
New +$4M

Similar funds

Caption Management's Q2 2025 Portfolio in Review

As of Q2 2025, Caption Management held 2,015 positions worth $9.03B, down 13% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management withdrew a net $1.22B in Q2 2025, closing 636 positions and reducing 307 holdings. Its most notable exit was Microsoft, an estimated $394M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 79% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Caption Management opened a new position in Skechers worth $20.1M.

  • Caption Management's largest Q2 2025 buy was Skechers: 317,932 shares worth $20.1M.
  • Caption Management added most to Kellanova in Q2 2025, an estimated $15.3M increase.
  • Caption Management's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $121M.
  • Caption Management fully exited Microsoft in Q2 2025, selling an estimated $394M.
  • Caption Management's ten largest holdings make up 18% of its $9.03B portfolio in Q2 2025.
  • Caption Management opened 576 new positions and closed 636 in Q2 2025.
  • Caption Management's portfolio value fell 13% quarter-over-quarter to $9.03B.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.